Navigation Links
Study examines adverse effects among different radiation therapies for prostate cancer
Date:4/17/2012

WASHINGTON, D.C. In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT, according to a study in the April 18 issue of JAMA, a theme issue on comparative effectiveness research.

Ronald C. Chen, M.D., M.P.H., of the University of North Carolina at Chapel Hill, presented the findings of the study at a JAMA media briefing at the National Press Club.

"Prostate cancer is the most common malignancy in men, with more than 200,000 diagnoses and 30,000 deaths per year. Recent advances in technology have led to costlier treatments such as minimally invasive radical prostatectomy, intensity-modulated radiation therapy, and proton therapy. The adoption of these technologies resulted in a $350 million increase in health care expenditures in 2005 alone," according to background information in the article. Various organizations have called for comparative effectiveness research of localized prostate cancer treatments. "The clinical benefit from these newer treatments is unproven, and comparative effectiveness research examining different radiation techniques is lacking," the authors write.

Dr. Chen and colleagues conducted a study to examine the comparative adverse effects and disease control outcomes after different radiation techniques in a recent cohort of prostate cancer patients. Specifically, the researchers compared IMRT, which has been rapidly adopted and is currently the most commonly used technique, with the older conformal radiation therapy; and compared proton therapy, the use of which also has increased, with IMRT. The population-based study used Surveillance, Epidemiology, and End Results-Medicare-linked data from 2000 through 2009 for patients with localized prostate cancer. The primary outcomes measured were rates of gastrointestinal adverse effects (such as rectal bleeding or diarrhea) and urinary adverse effects, erectile dysfunction, hip fractures, and receipt of additional cancer therapy as an indicator for disease recurrence.

The use of IMRT vs. conformal radiation therapy increased from 0.15 percent in 2000 to 95.9 percent in 2008. In the propensity-score adjusted analysis (n = 12,976), the researchers found that men treated with IMRT were less likely to receive a diagnosis of gastrointestinal adverse effects and hip fracture but more likely to receive a diagnosis of erectile dysfunction. Also, IMRT patients were nearly 20 percent less likely to receive additional cancer therapy.

In a propensity score-matched comparison between IMRT and proton therapy (n = 1,368), IMRT patients had a 34 percent lower risk of gastrointestinal adverse effects. There were no significant differences in rates of other adverse effects or additional therapies between IMRT and proton therapy.

"Proton therapy is a high-profile, high-cost prostate cancer treatment. Since 2007, multiple proton facilities have been built, and direct-to-consumer advertising is likely to lead to a substantial increase in use," the authors write. "Overall, our results do not clearly demonstrate a clinical benefit to support the recent increase in proton therapy use for prostate cancer."

The researchers add that the findings that patients receiving IMRT were less likely than those receiving conformal radiation therapy to undergo additional cancer treatments is consistent with the use of IMRT to deliver dose-escalated treatment, resulting in improved cancer control, as demonstrated by randomized trials. "Taken together, these results suggest that IMRT facilitated radiation dose escalation without compromising acceptable long-term morbidity."

"Comparative effectiveness research in localized prostate cancer treatments is needed because of the large number of men with this disease and the continued trend of a rapid increase in use of newer and costlier treatments with unproven clinical benefit," the authors write.


'/>"/>
Contact: Dianne Shaw
dgs@med.unc.edu
919-923-6012
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2018)... Wilmington, Delaware (PRWEB) , ... September 02, 2018 ... ... new hotel that merges hospitality with positive social change. The hotel itself, which opened ... entrepreneurs, artists, thought leaders, innovators, lawmakers or more. , Eaton Hotel DC currently ...
(Date:9/1/2018)... ... August 31, 2018 , ... SignatureCare Emergency Center is looking to award ... semester to a deserving student. Get your applications in now as the deadline is ... Hanna Wu who is a medical student at Texas Southern University. Wu was inspired ...
(Date:9/1/2018)... ... 01, 2018 , ... September is Animal Pain Awareness Month, ... (IVAPM) that aims to encourage pain management for all animals through education and ... pet owners of the many forms of pain and the importance of pain ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... host an Open House on Wednesday, September 12 from 1:00-3:00 pm. ... Grand Rapids, as well as tour the facility, meet our staff and learn ...
(Date:8/31/2018)... ... August 31, 2018 , ... The social impact documentary feature film on ... and NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has been faring well ... Film International Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, and Top ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... AccentCare, ... August 31, 2018, making its regional Texas Home Health operations the largest ... home health, hospice, and personal care services. , Texas Home Health operations serve ...
(Date:9/12/2018)... ... 2018 , ... Surgical Theater will be exhibiting at the ... The IT + Revenue Cycle Conference provides Surgical Theater with a great opportunity ... Precision Virtual Reality™ medical visualization platform. This 360VR technology allows patients to walk ...
(Date:9/7/2018)... ... September 06, 2018 , ... CTL Medical Corporation ... its commercial spine business, which includes its complete portfolio of spine-related patents and ... result from it. The deal will make CTL Medical the world’s exclusive provider ...
Breaking Medicine Technology: